» Articles » PMID: 2910640

Oral Dipyridamole Increases Plasma Adenosine Levels in Human Beings

Overview
Publisher Wiley
Specialty Pharmacology
Date 1989 Jan 1
PMID 2910640
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Plasma adenosine levels in five healthy volunteers for 5 consecutive days showed far less intrasubject than intersubject variation (p less than 0.0001), indicating that plasma adenosine levels are relatively constant during this period. Plasma adenosine levels were then measured in a different group of five healthy subjects for a 5-day control period and during a 5-day course of oral dipyridamole at a dose of 100 mg every 6 hours. Intrasubject comparisons showed that plasma adenosine levels were significantly higher during the 5 days of dipyridamole administration than during the control period (p = 0.017) and that this increase was most significant after 48 hours of drug (p less than 0.001) administration. The average increase was 0.133 mumol/L (60%) with a range of 0.063 to 0.197 mumol/L (37% to 212%) during the last 3 days. A significant positive correlation was noted between plasma adenosine and dipyridamole levels (p = 0.001). We conclude that adenosine levels are relatively stable for an individual and are maximally increased after 2 days of oral dipyridamole.

Citing Articles

The Purinergic System as a Target for the Development of Treatments for Bipolar Disorder.

Goncalves M, Andrejew R, Gubert C CNS Drugs. 2022; 36(8):787-801.

PMID: 35829960 PMC: 9345801. DOI: 10.1007/s40263-022-00934-0.


Performance of Plasma Adenosine as a Biomarker for Predicting Cardiovascular Risk.

Simard T, Jung R, Di Santo P, Ramirez F, Labinaz A, Gaudet C Clin Transl Sci. 2020; 14(1):354-361.

PMID: 33264483 PMC: 7877863. DOI: 10.1111/cts.12886.


High-throughput screening for modulators of ACVR1 transcription: discovery of potential therapeutics for fibrodysplasia ossificans progressiva.

Cappato S, Tonachini L, Giacopelli F, Tirone M, Galietta L, Sormani M Dis Model Mech. 2016; 9(6):685-96.

PMID: 27125279 PMC: 4920148. DOI: 10.1242/dmm.023929.


Circulating adenosine increases during human experimental endotoxemia but blockade of its receptor does not influence the immune response and subsequent organ injury.

Ramakers B, Riksen N, Van Den Broek P, Franke B, Peters W, van der Hoeven J Crit Care. 2011; 15(1):R3.

PMID: 21211004 PMC: 3222030. DOI: 10.1186/cc9400.


Translational therapeutics of dipyridamole.

Kim H, Liao J Arterioscler Thromb Vasc Biol. 2008; 28(3):s39-42.

PMID: 18174451 PMC: 2615560. DOI: 10.1161/ATVBAHA.107.160226.